PALISADE BIO, INC. - PALI
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Squadron Master Fund LP | 3.0% | 4,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Squadron Capital Management LLC | 3.0% | 4,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Matthew Sesterhenn | 3.0% | 4,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | William Blank | 3.0% | 4,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 15,746,829 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 15,746,829 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 15,746,829 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 15,746,829 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 7.0% | 10,495,252 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 7.0% | 10,495,252 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 7.0% | 10,495,252 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 15,200,117 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 15,200,117 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 15,200,117 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | David Kroin | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Special Opportunities Fund, LP. | 0.0% | 0 | View |
| Feb 10, 2026 | SCHEDULE 13G | Octagon Capital Advisors LP | 6.4% | 9,567,898 | View |
| Feb 10, 2026 | SCHEDULE 13G | Octagon Investments Master Fund LP | 6.4% | 9,567,898 | View |
| Feb 10, 2026 | SCHEDULE 13G | Ting Jia | 6.4% | 9,567,898 | View |
| Dec 08, 2025 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 9.99% | 14,885,421 | View |
| Dec 08, 2025 | SCHEDULE 13G | Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | 8,897,507 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.